Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer

Condition:   Breast Cancer Interventions:   Drug: Letrozole;   Drug: Palbociclib;   Drug: Goserelin;   Diagnostic Test: Oncotype DX Breast Recurrence Score Sponsors:   NSABP Foundation Inc;   Genomic Health®, Inc.;   Pfizer Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials